acssart glp-1 Advanced Metabolic Extra Strength Ascend Custom GLP-1 – Ascend

Description

By Vital Nutrients

The GLP-1 arena is currently dominated by two giants, Novo Nordisk and Eli Lilly, forming a duopoly in this high-growth field

If you lost access to semaglutide or tirzepatide, you have options.

Thus, the SELECT trial exceeded expectations (many commentators predicted the topline reduction to be likely sub-20%), but also underlined the need for further outcomes trials to clarify other potential benefits, as well as, for competitors, meeting or exceeding the performance of Wegovy

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88